1. Introduction {#s0005}
===============

Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy in adults, with a prevalence of about 1 in 8000 people worldwide. It is an autosomal dominant disorder due to an unstable cytosine-thymine-guanine triplet repeat (\[CTG\]n) expansions on chromosome 19 ([@bb0065]), showing no definitive correlation with phenotypic expression ([@bb0185]). DM1 can be classified into four clinical forms: congenital, childhood and classical or late-onset ([@bb0050], [@bb0060]). Classical DM1 form is a multisystem disorder ranging from mild to more severe phenotypes and affecting many organs and tissues, including central nervous system (CNS), this finally responsible of cognitive and behavioural dysfunctions.

Several studies have demonstrated that DM1 patients show a selective impairment in cognitive functioning, particularly in attentional, visuo-spatial, and executive domains ([@bb0115], [@bb0200]); the existence of a "DM1-related-dysexecutive-syndrome" has been already proposed ([@bb0105]). Intelligence assessment documented an IQ below average in the DM1 population as compared to healthy subjects, with no clear evidence of a progressive decline ([@bb0105], [@bb0075]).

Beside cognitive impairments, in DM1 patients neuropsychiatric comorbidities are frequently reported with variable pathologic behavioural patterns: lack of interest (apathetic behaviour), a decreased emotional participation and an increased irritability are the main clinical features, defined by some authors as "an emotional imbalance" ([@bb0105], [@bb0090]); moreover, a high prevalence of dysfunctional personality has been described ([@bb0115], [@bb0200], [@bb0150]).

Previous studies have documented brain abnormalities in DM1 through different imaging techniques and investigated their relationship with cognitive impairment without reaching univocal conclusions. Voxel-based morphometry (VBM) technique showed grey matter (GM) atrophy in several regions of temporal and frontal lobes, hippocampi and thalami ([@bb0195], [@bb0120], [@bb0145]); some studies revealed non-specific pathological findings such as ventricular enlargement and white matter (WM) hyperintensities in different cerebral lobes ([@bb0120], [@bb0140]); single photon emission tomography and PET studies demonstrated hypoperfusion and glucose hypometabolism of frontal and temporal lobes ([@bb0195], [@bb0110]). Recent studies adopting tractography evaluation ([@bb0120], [@bb0205]) provide data showing microstructural WM damage in interhemispheric, corticospinal and limbic pathways and in frontal, temporal, parietal and occipital lobes. To date, only one study demonstrates that brain atrophy and white matter involvement are progressive over time in DM1 ([@bb0035]).

Although considerable structural CNS involvement on one hand and cognitive deficits on the other hand have been detected in DM1, only few studies investigate their relationship. Some studies have found significant correlations between MR imaging features and neuropsychological profiles ([@bb0195], [@bb0205], [@bb0030]), while others did not ([@bb0120], [@bb0140]).

To this purpose we investigated the structural alterations of GM and WM in a sample of adult-onset DM1 patients and evaluated their relationship with clinical and cognitive variables.

2. Material and methods {#s0010}
=======================

Thirty patients (24 males, 6 females; mean age 44.6 ± 12.4 years; age range 24--67 years) with clinical and genetic diagnosis of adult form of DM1, according the International Consortium for myotonic dystrophies guidelines ([@bb0070]), were consecutively recruited at Neurological clinic of University of Pisa. Exclusion criteria were mental retardation (IQ \< 70), severe visual impairment, psychiatric illness and a history of substances abuse. None of the patients presented motor or coordination disability sufficient to account for possible delay in any of the neuropsychological tests administered. Patients were grouped on the basis of the number of \[CTG\]n expansions: 12 patients (40%) were classified as E1 (\< 150 \[CTG\]n) and 18 patients (60%) as E2 (150--1000 \[CTG\]n). The mean disease duration from symptoms onset to the MRI examination was 16.5 ± 11.8 years, while age at onset was 29.0 ± 12.0 years. Patients\' mean educational level was 11.3 ± 3.4 years.

Control group was retrospectively selected from our database and included 30 healthy subjects (22 males, 8 females; mean age 44.8 ± 12.6 years; age range 27--68 years) for VBM analyses and 21 subjects (14 males, 7 females; mean age 44.6 ± 12.7 years; age range 27--61 years) for diffusion tensor imaging (DTI) analysis. Age and gender did not significantly differ between patients and controls either for VBM (Mann--Whitney *U* test p = 0.95 for age; Fisher\'s exact test, two tailed p = 0.54 for sex), and for DTI (Mann--Whitney *U* test p = 0.33 for age; Fisher\'s exact test, two tailed p = 0.92 for sex). All healthy controls beside not to be affected by neurological or psychiatric disorders, had negative neurological examination and no family history for neuropsychiatric illness.

2.1. Neuropsychological evaluation {#s0015}
----------------------------------

An experienced neuropsychologist, who was unaware of the clinical and MRI data, performed the neuropsychological evaluation. For assessment of immediate memory Immediate and Delayed Recall (IR, DR) of Rey Auditory Verbal Learning Test (RAVLT), Immediate and Delayed Recall (IR, DR) of Rey Osterrieth Complex Figure (ROCF), digit span and Corsi Block-tapping Test (CBT) were administered. Trail Making Tests (TMT-A and TMT-B) were used to assess selective attention and cognitive flexibility and Stroop Test was used to assess automatic response inhibition. Frontal and executive functions were examined by phonemic verbal fluency test (FAS), Frontal Assessment Battery (FAB) and Modified Wisconsin Card Sorting Test (WCST). Rey-Osterrieth Complex Figure was used to assess spatial organization and visuo-constructional skills (ROCF-copy). Patients\' raw scores were corrected according to Italian normative values ([@bb0175], [@bb0095]). Percentages of impairment of DM1 patients who showed significant neuropsychological dysfunctions across different cognitive domains were established using Italian normative data for both, score adjustment (sex, age, education) and definition of cut-off thresholds; the latter have been determined as the lower limit of the 95% tolerance interval for a confidence level of 95%.

2.2. Data acquisition {#s0020}
---------------------

MRI imaging was performed with a 3T scanner (Discovery MR750 3.0 T, GE Healthcare, Milwaukee) equipped with an 8-channel head coil with ASSET-technology. The examination protocol included a sagittal CUBE T2 FLAIR sequence (TR 8000 ms; FOV 256 mm; matrix 256 × 256; thickness 1.0 mm; spacing 0 mm; NEX 1.0), a sagittal high resolution 3D T1weighted images with isotropic voxels (TR 8.1 ms; TE 3.2 ms; TI 450 ms; flip angle 12°; FOV 256 mm; matrix 256 × 256; thickness 1.0 mm; spacing 0 mm; NEX 1.0) and DTI performed by using a multiacquisition echoplanar sequence (TR 7000 ms; TE minimum; FOV 240 mm; matrix 128 × 128; thickness 2.9 mm; spacing 0 mm; diffusion gradients applied in 25 directions with b factor = 1000 s/mm^2^ and 1 b0 volume).

2.3. GM evaluation {#s0025}
------------------

The evaluation of GM atrophy was performed with a Region of Interest (ROI) based method and using VBM analysis.

In ROI based method FLAIR images, reformatted in axial slices (thickness 4 mm without spacing), were manually segmented using software AW VolumeShare 4 (ADVANTAGE WORKSTATION 4.3, GE Healthcare, Milwaukee) to measure the parenchymal volume and total intracranial volume. Brain parenchymal fraction (BPF) was calculated through the ratio of brain parenchymal to intracranial volume and was considered as an expression of the degree of atrophy, as done in previous studies of volumetric analysis of DM1 patients ([@bb0085]). Correlations between BPF values and clinical (age, disease duration) and neuropsychological scores were evaluated by using Pearson correlation coefficient, considering p-value statistically significant at p \< 0.05.

### 2.3.1. VBM {#s0030}

The automated analysis of T1 structural data was carried out by FSL-VBM ([@bb0040]), an optimised VBM protocol ([@bb0055]) carried out with FMRIB software library package (FSL) ([@bb0165]). As preprocessing step T1 images were corrected for WM lesions using the lesion filling toolbox available in FSL ([@bb0015]). Structural images were brain-extracted using BET (Brain Extraction Tool) ([@bb0155]), and then they were automatically segmented into GM, WM and cerebrospinal fluid (CSF) tissue-type by FAST4 tool ([@bb0210]). The GM volume images were aligned to the Montreal Neurological Institute (MNI) 152 standard space ([@bb0100]) by the affine registration tool FLIRT ([@bb0080]), followed by non-linear registration using FNIRT ([@bb0010]). The registered GM images of an equal number of healthy controls and DM1 patients were averaged and flipped along the x-axis to create a left-right symmetric, study-specific grey matter template. After that all native GM images were non-linearly registered to this study-specific template, modulated and smoothed with an isotropic Gaussian kernel with a sigma of 3 mm.

A voxel-wise General Linear Model (GLM) was applied using permutation-based non-parametric testing (5000 permutations), correcting for multiple comparisons across space (p \< 0.001) by threshold-free cluster enhancement (TFCE) option ([@bb0160]). Since voxel based quantification of atrophy is influenced by aging ([@bb0045]) we inserted age and gender of patients and controls as covariate variables within the GLM matrix.

In order to establish a possible relationship with VBM changes multiple regression analyses were also performed inserting neuropsychological scores in different GLM design matrix, using age and gender as covariates of no interest (TFCE p \< 0.05 corrected for multiple comparisons).

The description of statistical maps obtained from VBM analysis was based on Anatomical Automated Labeling (AAL) Atlas ([@bb0180]).

2.4. WM evaluation {#s0035}
------------------

Sagittal CUBE T2 FLAIR sequence was also acquired in order to establish recurrence, localization and patterns of distribution of white matter hyperintense lesions in DM1 patients. WM alterations were evaluated with a visual scale according to a modified version of the Fazekas scale ([@bb0130]) on reformatted FLAIR images. A quantitative measure of the white matter lesions was performed with a ROI based approach by manually contouring the WM lesions. The lesion load (LL%) was calculated through the ratio of lesions volume to brain parenchymal volume and expressed as a percentage. Correlations between lesions indices (Fazekas scale and LL%) and clinical and neuropsychological scores were evaluated by using Spearman and Pearson correlation coefficients, respectively for Fazekas scale and LL%, considering p-value statistically significant at 0.05.

### 2.4.1. TBSS {#s0040}

DTI sequence was acquired in order to perform tract-based spatial statistical (TBSS) analysis ([@bb0170]).

The preprocessing steps on the raw diffusion data consisted in minimizing the distortion relative to gradient application using 'eddy current correction' tool and to perform brain-extraction using BET. DTIfit toolbox ([@bb0020]) was used to fit a diffusion tensor model at each voxel of the preprocessed DTI images in order to obtain fractional anisotropy (FA), mean diffusivity (MD) and eigenvalues (L1, L2, L3) maps for each subject. Maps of axial diffusivity (AD) were evaluated (L1 maps) and maps of radial diffusivity (RD) were calculated averaging L2 and L3 maps. All subjects\' DTI-derived maps were nonlinear registered to a target image (FMRIB58_FA) using FNIRT. After that, a mean FA image was calculated and thinned (threshold 0.2) in order to create a mean FA skeleton which represented the centres of all tracts common to the group. For each subjects, registered DTI-derived maps were then projected onto this skeleton and the resulting data fed into voxelwise cross-subject statistics.

Group differences between patients and controls in DTI-derived indices were performed using permutation-based non-parametric testing (5000 permutations), correcting for multiple comparisons across space (p \< 0.05) by TFCE option ([@bb0100]). Age and gender were used as covariates of no interest in the statistical design matrix.

Multiple regression analyses were also performed using neuropsychological variables in different GLM design matrix to evaluate relationship with DTI-derived indices, inserting age and gender as covariates of no interest (TFCE p \< 0.05 corrected for multiple comparisons).

JHU DTI-based white-matter atlas (ICBM-DTI-81 white-matter labels atlas) has been superimposed to statistical maps in order to identify the WM tracts ([@bb0125]).

2.5. Ethics statement {#s0045}
---------------------

The research was conducted according to the principles expressed in the Declaration of Helsinki. The study was authorized by the Local Ethics Committee and written informed consent was obtained from all the study participants.

3. Results {#s0050}
==========

3.1. Cognitive profile {#s0055}
----------------------

TMT-A was impaired in 17.2% of patients, TMT-B in 14.8%, FAB in 20.0%, Stroop test as in bracket (Error Interference in 20.7%, Time Interference in 27.6%) and FAS in 26.7%; impairment in WCST was detected in 36.7% of patients as for Categorization ability, while Perseverations were found in 40.0%.

CBT showed impairments in 40.0% of patients, while 16.7% had impairments in Digit Span. As for delayed recall memory, 3.3% showed RAVLT-DR impaired performances, while 10.0% had impaired ROCF-DR. Motor planning and visuo-spatial abilities, tested using ROCF-copy, ranked below the normal range, in 40.0% of patients.

Neuropsychological findings are summarized in [Supplementary Table 1](#ec0005){ref-type="supplementary-material"}.

3.2. Grey matter atrophy {#s0060}
------------------------

BPF value in DM1 subjects was 0.760 ± 0.035 and correlated with visuo-spatial and executive performance (TMT-A, TMT-B, ROCF-copy and WCST categorization) (p \< 0.05).

VBM revealed several clusters of reduced cortical GM in DM1 patients compared to healthy controls (TFCE p \< 0.001 corrected for multiple comparisons). Atrophy was diffuse in both cerebral hemispheres ([Supplementary Table 2](#ec0010){ref-type="supplementary-material"}) and in particular it was located in perirolandic, orbitofrontal, dorsolateral frontal, insular, temporo occipital, parietomesial, anterior and posterior cingulated areas ([Fig. 1](#f0005){ref-type="fig"}).

VBM analysis showed a negative relationship between RAVLT-DR scores and the grade of atrophy respectively in left postcentral (AAL 57), left middle and inferior temporal gyri (AAL 85 89) and left supramarginal gyrus (AAL 63) (TFCE p \< 0.05 corrected for multiple comparisons) ([Fig. 2](#f0010){ref-type="fig"}).

3.3. White matter alterations {#s0065}
-----------------------------

WM alterations, evaluated visually with modified Fazekas scale, classified 5 patients (16.7%) as grade 0 (absence of lesions), 11 patients (36.7%) as grade 1 (mild changes), 10 patients (33.3%) as grade 2 (moderate changes), while 4 patients (13.3%) were classified as grade 3 (severe changes). No correlation between Fazekas scale and clinical and neuropsychological scores was demonstrated (p \> 0.05).

LL% measured with ROI based method was 0.7 ± 0.9% (range 0--4.1%) and no significant correlation was found with clinical and neuropsychological features (p \> 0.05).

TBSS analysis revealed several areas of decreased FA and increased RD, MD and AD in white matter of DM1 patients compared to healthy controls (TFCE p \< 0.05 corrected for multiple comparisons). DTI indexes were extensively impaired in association and projection tracts of both hemispheres ([Supplementary Table 3](#ec0015){ref-type="supplementary-material"}, [Supplementary Table 4](#ec0020){ref-type="supplementary-material"}, [Supplementary Table 5](#ec0025){ref-type="supplementary-material"}, [Supplementary Table 6](#ec0030){ref-type="supplementary-material"}). FA and MD changes involved the brainstem and the cerebellum of the DM1 patients with respect to healthy controls while RD and AD only the brainstem ([Fig. 3](#f0015){ref-type="fig"}).

Multiple regression analyses to correlate neuropsychological tests to WM abnormalities showed areas of significant negative relationship between RD and ROCF-copy, RAVLT-DR and CBT scores; moreover, AD had a significant negative relationship with RAVLT-DR and digit span scores (TFCE p \< 0.05 corrected for multiple comparisons) ([Fig. 4](#f0020){ref-type="fig"}).

4. Discussion {#s0070}
=============

4.1. Cognitive profile {#s0075}
----------------------

According to previous evidences about cognitive impairment in DM1 ([@bb0115], [@bb0200], [@bb0120]), most of our patients presented diffuse neuropsychological dysfunction, mainly characterized by impairment in executive and mnesic domains with visuo-spatial component (WCST categorization 36.7%, WCST perseverations 40%, ROCF-copy 40.0%, CBT 40.0%). DM1 cognitive performance points out patients\' relevant and likely specific difficulties in tasks which represent currently used paradigms to test executive control ability. In a smaller portion of patients, we detected cognitive impairment also in attentive and other executive domains, as showed by FAS, FAB, STROOP, TMT-A and Digit span. Despite wide neuropsychological impairment, opposite to visuo-spatial domain, our study elucidated a preservation of verbal abilities (about 80%) in these patients, this suggesting the need for systematic assessment of memory and cognitive planning in similar studies.

4.2. Grey matter atrophy {#s0080}
------------------------

The BPF that we obtained was in line with value measured in DM1 patients and reduced respect to the normal population ([@bb0085]), confirming a global loss of central nervous tissue in this myopathy. The BPF showed a significantly correlation with age (p \< 0.001), indicating that the central nervous system atrophy in the adult form of DM1 progresses with age as in the normal elderly and differently from the juvenile form of DM1 where the atrophy is present from the beginning of the disease in early childhood ([@bb0030]). Brain volume loss has been correlated with disability progression and cognitive impairment in other neurological disorders, such as multiple sclerosis (MS), but up to now data about DM1 are scarce ([@bb0085]); a better knowledge about brain volume loss may have important clinical implications for treatment and prognosis in DM1.

Notably in our sample the main executive dysfunction as well as memory and visuo-spatial impairment was not related to focal atrophy in specific brain regions, as already reported by previous studies ([@bb0110]), but they were associated to the overall cerebral atrophy expressed by BPF.

The atrophy at VBM is widely distributed and includes the cortical areas pertaining the sensori-motor and cognitive brain networks. The involvement of these brain areas fits with the supposed motor defect in DM1 ([@bb0025]) and with the well-known impairment in cognitive functioning ([@bb0115], [@bb0200]).

Our results were in line with recent reports ([@bb0030]) showing similar GM atrophy pattern, but differently from the previous experience, we also reported a significant association between GM atrophy in temporo-parietal areas (left postcentral, left middle and inferior temporal gyri and left supramarginal gyrus) and specific neuropsychological tests investigating verbal learning. Although these tests are not significantly impaired in DM1, the reported correlation could support the putative role of these regions in conceptual representation and recognition of words meaning ([@bb0005]). Indeed, temporo-parietal cortex includes multimodal associative areas that receive auditory, visual, and somatosensory inputs, and are implicated in processing the phonological and semantic aspect of language.

To our knowledge some studies report controversial associations between cortical atrophy and cognitive deficits, in particular with nonverbal episodic memory and cognitive flexibility ([@bb0195], [@bb0145]); on the other hand, others studies failed to provide consistent associations in that ([@bb0120], [@bb0140]).

4.3. White matter alterations {#s0085}
-----------------------------

The WM lesions have been frequently reported in patients with DM1 ([@bb0120], [@bb0140]) and predominate at level of frontal and temporal lobes. An important result of our study is the lack of correlation between the LL% and the neuropsychological defects. On the other hand, the TBSS results indicate that projection and associative fibres are extensively affected in DM1 patients with an involvement of the normal appearing white matter beyond the signal changes detected with conventional MR imaging.

We found interesting similarities between the pattern of WM damage revealed in our patients and recent whole-brain DT MRI studies ([@bb0120], [@bb0205], [@bb0030]) consisting in a significant overlap of altered DTI indexes along several fibre bundles.

Greater white matter abnormalities (as indicated by RD or AD changes) were associated with lower score at neuropsychological tests indicating worse functioning. In our study the cognitive performance in visuomotor coordination and working memory tasks (ROCF-copy, CBT, digit span) was associated to microstructural damage detected in major associative tracts as corpus callosum ([@bb0135]), while scores in visuo-spatial and episodic verbal memory were associated mainly to associative tracts of the internal capsule and corona radiate, that collectively connect neocortex to deeper brain structures.

From a neuropsychological perspective a cognitive-behavioural dysfunction usually depends upon both the size and site of a given lesion. Although certain areas in the brain can be critical for specific cognitive functions, also small but diffuse WM subcortical lesions can produce major effects since they disrupt interconnections between brain regions in distributed neural networks ([@bb0095]).

This is the case of DM1 in which neuropsychological studies suggest that the dysfunction may occur not only in distinct CNS regions but also in complex neuronal networks, this implying that patients\' cognitive profile is likely to be the result of a multifactorial process in which genetic and epigenetic factors interact through complex mechanisms related to brain plasticity, compensation, neurodegeneration or neurodevelopmental defects. Since the DTI explores complex neuronal networks and can detect abnormalities in the normal-appearing white matter, this technique has to be tested as a possible marker of the progression of cognitive impairment of DM1.

Finally, it has to be considered that, beside cognitive deficits, DM1 patients suffer from an emotional imbalance expressed by symptoms like depression, lack of interest, decreased emotional participation. While it is accepted that the disruption of white matter tracts, has a clinical relevance in several developmental and psychiatric disorders ([@bb0190]), we cannot exactly evaluate the contribution of the psychiatric component to the cognitive deficit because a specific correlation between psychiatric scales and MR parameters was not performed. This should be the object to be addressed with further studies.

The following are the supplementary data related to this article.Supplementary Table 1Neuropsychological functioning indicated as means and standard deviations of corrected scores; percentages of subjects with impaired performance are related to available cut-off scores of normality (\> 95% of the tolerance limit of the normal population distribution).Supplementary Table 1Supplementary Table 2VBM results: size of clusters of cortical atrophy in DM1 patients compared to healthy controls defined in AAL map (TFCE p \< 0.001 corrected for multiple comparisons). Coordinates are expressed in MNIstandard space. Age and gender were used as covariate of no interest.Supplementary Table 2Supplementary Table 3TBSS results: size of clusters of FA in DM1 patients compared to healthy controls defined in ICBM-DTI-81 white-matter labels atlas (TFCE p \< 0.05 corrected for multiple comparisons). Coordinates are expressed in MNI standard space. Age and gender were used as covariate of no interest.Supplementary Table 3Supplementary Table 4TBSS results: size of clusters of MD in DM1 patients compared to healthy controls defined in ICBM-DTI-81 white-matter labels atlas (TFCE p \< 0.05 corrected for multiple comparisons). Coordinates are expressed in MNI standard space. Age and gender were used as covariate of no interest.Supplementary Table 4Supplementary Table 5TBSS results: size of clusters of RD in DM1 patients compared to healthy controls defined in ICBM-DTI-81 white-matter labels atlas (TFCE p \< 0.05 corrected for multiple comparisons). Coordinates are expressed in MNI standard space. Age and gender were used as covariate of no interest.Supplementary Table 5Supplementary Table 6TBSS results: size of clusters of AD in DM1 patients compared to healthy controls defined in ICBM-DTI-81 white-matter labels atlas (TFCE p \< 0.05 corrected for multiple comparisons). Coordinates are expressed in MNI standard space. Age and gender were used as covariate of no interest.Supplementary Table 6
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![VBM analysis reveals clusters of grey matter atrophy (in green) in DM1 patients compared to healthy controls superimposed on axial slices (a) or volumes (b) of MNI standard brain (TFCE p \< 0.001 corrected for multiple comparisons). Clusters are diffuse in both hemispheres, particularly in perirolandic, orbitofrontal, dorsolateral frontal, insular, temporo occipital, parietomesial, anterior and posterior cingulated areas. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr1){#f0005}

![Negative relationship between RAVLT-DR scores and grade of atrophy (in green) in DM1 patients superimposed on volume (a) and coronal and axial slices (b) of MNI standard brain (TFCE p \< 0.05 corrected for multiple comparisons). Clusters are located in left postcentral\*, left middle and inferior temporal^+^ gyri and left supramarginal° gyrus. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr2){#f0010}

![TBSS maps show the tracts of significantly decreased FA (a, in blue) and the tracts of significantly increased RD (b, in red), MD (c, in yellow) and AD (d, in purple) in DM1 patients compared to healthy controls superimposed on axial and sagittal slices of MNI standard brain (TFCE p \< 0.05 corrected for multiple comparisons). Green indicates the skeleton template. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr3){#f0015}

![Multiple regression analyses reveal negative relationship (in red) between RD and ROCF-copy (a), RAVLT-DR (b) and CBT (c) scores in DM1 patients. AD had a significant negative relationship (in purple) with RAVLT-DR (d) and digit span (e) scores in DM1 patients. Results are superimposed on axial and sagittal slices of MNI standard brain (TFCE p \< 0.05 corrected for multiple comparisons). Green indicates the skeleton template. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr4){#f0020}
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